NCT03390790View on ClinicalTrials.gov

Lidocaine for Pain After Urodynamic Testing

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

January 25, 2018

Primary Completion Date

March 29, 2019

Study Completion Date

March 29, 2019

Conditions
Voiding DisordersOveractive BladderUrinary Incontinence
Interventions
DRUG

Lidocaine gel 2%

If assigned to this intervention via randomization, participants will receive lidocaine (numbing) gel prior to their urodynamics procedure.

OTHER

Standard lubricant gel

If assigned to this intervention via randomization, participants will receive standard lubricant gel prior to their urodynamics procedure.

Trial Locations (1)

07960

Atlantic Health System, Morristown

Sponsors
All Listed Sponsors
lead

Atlantic Health System

OTHER

NCT03390790 - Lidocaine for Pain After Urodynamic Testing | Biotech Hunter | Biotech Hunter